Skip to main content

View full-text article in PMC

. 2004 Apr 1;10(7):1047–1051. doi: 10.3748/wjg.v10.i7.1047

Table 2.

Effects of pioglitazone on liver functions in fibrotic rats (mean ± SD)

Group	n	ALT (U/L)	AST (U/L)
Control	10	41.09 ± 6.58	136.34 ± 31.23
Model	8	105.00 ± 23.71^d	397.86 ± 67.32^d
PI	10	58.64 ± 11.40^b	259.58 ± 45.89^b
PII	10	87.32 ± 15.65^a	344.49 ± 28.10^a

^a

P < 0.05,

^b

P < 0.01 vs model group;

^d

P < 0.001 vs control group.